In vitro antileishmanial activity of inhibitors of steroid biosynthesis and combinations of antileishmanial agents.
D000493:Allopurinol / Q000031:analogs & derivatives / Q000494:pharmacology; D000499:Allylamine / Q000031:analogs & derivatives / Q000494:pharmacology*; D000588:Amines / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D000967:Antimony Sodium Gluconate / Q000494:pharmacology; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D004338:Drug Combinations; D006801:Humans; D007654:Ketoconazole / Q000494:pharmacology; D007891:Leishmania / Q000187:drug effects*; D009281:Naphthalenes / Q000494:pharmacology*; D012263:Ribonucleosides / Q000494:pharmacology; D000077291:Terbinafine
D000588:Amines; D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D004338:Drug Combinations; D009281:Naphthalenes; D012263:Ribonucleosides; D000499:Allylamine; C029178:naftifine; D000493:Allopurinol; D000077291:Terbinafine; D007654:Ketoconazole; D000967:Antimony Sodium Gluconate; C021958:allopurinol riboside